Navigation Links
Generex Touts Pipeline Potential of Antigen Express Subsidiary
Date:2/7/2013

WORCESTER, Mass. and TORONTO, Feb. 7, 2013 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today provided an overview of the current pipeline and potential of its wholly-owned subsidiary Antigen Express, Inc. (www.antigenexpress.com). While the Company is currently in a late Phase IIb trial of a very promising new immunotherapy for early breast cancer (AE37), the Company has made concrete headway in demonstrating a robust pipeline for AE37 indications beyond breast cancer, as well as for the technology behind it. Immediately behind its Phase III-ready breast cancer program, the Company has completed a Phase I prostate cancer trial and established a protocol for Phase II. While Herceptin targets the same tumor-associated protein as does AE37 therapy, Herceptin is not approved for breast cancer patients with low levels of HER2 expression, limiting Herceptin treatment to roughly 25% of breast cancer patients. Low levels of HER2 protein have been shown on several cancers, including men with prostate cancer. AE37 is being further researched in this larger population of patients whose tumors express only low levels of HER2.

(Logo: http://photos.prnewswire.com/prnh/20110106/NY25057LOGO-b)

While breast and prostate cancers are the initial indications being investigated for AE37, nearly all cancers of the gastrointestinal tract as well as lung, ovarian, bladder, and other cancers also express low levels of HER2. AE37 future research may help establish its role in many cancers in addition to breast and prostate cancer. A unique aspect of Antigen Express technology, which has enabled the promising results obtained so far from the AE37 Phase IIb trial in early breast cancer, is the Ii-Key technology
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
2. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
3. Generex Augments Antigen Express Scientific Advisory Board
4. Generex Reports on Inaugural AE37 Breast Cancer Vaccine Scientific Advisory Board Meeting
5. Generex Announces OncUView.tv Interviews Featuring the Antigen Express AE37 Breast Cancer Vaccine at ASCO 2012
6. Generex Announces Results of Annual Stockholders Meeting
7. Generex Addresses Recent Trading Volume in Shares of its Common Stock
8. Generex Announces Details of Investor Conference Call
9. Generex Provides an Overview of its Cancer Immunotherapy Product, AE37, and Potential in Early Breast Cancer Given Current and Potential Future Therapies
10. Generex Points to Potential of Antigen Express Technology Platform beyond Its AE37 Breast Cancer Vaccine
11. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... -- Report Details ... R&D and Sales Potentials ... Visiongain,s new report gives you revenue predictions for that industry ... data, R&D trends, opportunities, interviews and revenue forecasts. ... forecasted sales to 2025 at overall world market, submarket, product ...
(Date:9/3/2015)... 3,  2015 About artificial organs ... which are implanted or integrated into individuals ... include artificial heart, kidney, pancreas, and cochlear ... polysulfone, and porous polypropylene), biologics, ceramics, and ... These organs are incorporated with different technologies ...
(Date:9/3/2015)... Calif. , Sept. 3, 2015 Nevro ... company that is providing innovative evidence-based solutions for the ... will be presenting at the Morgan Stanley Global Healthcare ... City.  Nevro management is scheduled to ... accessible via a live audio webcast, accessible in the ...
Breaking Medicine Technology:World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 2World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 3World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 4World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 5World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 6World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 7Global Artificial Organ Market 2015-2019 2
... Seal Shield LLC today announced the new SILVER ... mouse, along with other infection prevention products, at the ... mouse has been designed to help prevent cross contamination ...   According to a bacteria study of ...
... Mass., June 28, 2011 Rcadia Medical Imaging today ... by the U.S. Patent and Trademark Office covering technology ... fully automatic analysis of Coronary CT Angiography (cCTA) studies ... disease (CAD) patients and optimize cardiology and radiology department ...
Cached Medicine Technology:Rcadia Medical Imaging Awarded Four U.S. Patents Covering Technology for Automated Analysis of Coronary CT Angiography 2
(Date:9/4/2015)... ... ... IVF New England, one of the largest and most successful fertility centers ... for women who wish to learn more about their fertility and egg freezing. , ... Elm Street, Manchester, NH from 6PM to 7PM , This hip, casual and informative ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... benefit Core Compassion Project. Core Compassion Project is a non-profit organization dedicated ... reduce the side effects of cancer treatments and recover their mobility, strength, and ...
(Date:9/4/2015)... Wailea, Maui HI (PRWEB) , ... September 04, 2015 , ... ... of the best ways for couples to explore, revitalize and strengthen their ‘couple-ness,’” ... Wietzel and his team at Four Seasons Resort Maui, the island’s only Forbes Five ...
(Date:9/4/2015)... ... September 04, 2015 , ... The USC Eye Institute is proud to ... by Doximity. Faculty, residents and staff are honored to have contributed to the ... of our ophthalmology residency program. Our faculty places a high priority on our educational ...
(Date:9/4/2015)... York, NY (PRWEB) , ... September 04, 2015 , ... ... meters qualifying heat, and followed up with victory in the men’s 400 meters final, ... (NACAC) Senior Track and Field Championships in San Jose, Costa Rica in August 2015. ...
Breaking Medicine News(10 mins):Health News:IVF New England to Host ManchVegas New Hampshire Fertility Happy Hour on October 15, 2015 in Manchester for Women Who Wish to Learn More About Fertility and Egg Freezing 2Health News:Girl’s Night Out to Benefit Core Compassion Project, Located at the Beautiful, Morning Glory Farm 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3
... a new tool to understand how cancers grow -- and ... They,ve been able to break apart human prostate tissue, extract ... genetically so that they spur cancer. Owen Witte, a ... Los Angeles, will present the findings on February 20, 2010, ...
... Sciences Research convenes a panel discussion, "Science in ... Topics will include:, Recommendations from Beyond Health ... Wood Johnson Foundation Commission to Build a Healthier ... approaches can inform public policy, How science-informed policy ...
... ... of "Sun Spark Purity" the company has already positioned itself as a powerful player in ... clients smaller quantities and samples that can be purchased via creditcards! , ... (PRWEB) February 20, 2010 -- The war is ...
... "Earth system" was, until recently, composed of several large-scale ... For example, atmospheric activity and carbon and phosphorus cycles ... 100 years or so, however, many human activities have ... the old equilibriums off-kilter. "Humans have, essentially, ...
... ... scientist and the leading voice of the stem cell revolution, is on a 10 city ... , ... 2010 -- Remarkable public interest in the stem cell phenomenon made a science book an ...
... , ... ... ... ...
Cached Medicine News:Health News:New tool illuminates connections between stem cells and cancer 2Health News:Sun Spark Purity Moves Aggressively into the Market of Pure Lidocaine Powder and Caffeine Powder 2Health News:Sun Spark Purity Moves Aggressively into the Market of Pure Lidocaine Powder and Caffeine Powder 3Health News:Arizona State University's Decision Theater offers balance to an off-kilter world 2Health News:Health: Surprise Best Seller is Stem Cell Book – Author in Spokane - 10 City Tour 2Health News:Idaho Legislators Stand for Health Care Freedom 2Health News:Idaho Legislators Stand for Health Care Freedom 3Health News:Idaho Legislators Stand for Health Care Freedom 4
... complete line of Surgical Access ...unlike any ... OnePort™ trocar system is actually four systems ... operationally flexible and clinically adaptive to all ... in disposability and bladed or dilating tip ...
Mini-Finesse 5mm Dilating Trocar, hook electrode, two lengths, mini or basic kit....
... The Thoracic Trocar Sleeve consists ... which is designed to prevent ... structures once the cavity has ... stability threads on the sleeve ...
... The TRISTAR is a full-featured trocar that consists ... The shield is designed to cover the pyramidal ... laceration once the abdominal or thoracic cavity has ... excessive force to insert is not required. , ...
Medicine Products: